An underground market for unapproved slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Investigational Treatment Acquiring Traction Online
The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Followers are encouraged to contact these accounts privately for source information, while also obtaining promotional offers.
Thriving Commerce on Social Networks
Separately, a robust market exists on messaging services, where communities with thousands of participants share comparison photos, administration instructions and claims of next-day UK delivery. Vendors promote the drug there before redirecting customers to other platforms for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Healthcare Experts Express Worries
However, physicians and pharmacists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.
Some experts stated the demand for retatrutide could be linked to the rising price of approved slimming products such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the British medical regulations.
Some content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate medicines, advertising, and customer regulations, risking penalties, legal action or prison.
Platform Reaction and Material Removal
According to the social media company, the platform has taken down violative material and prohibited related keywords and search suggestions. The company said it was dedicated to keeping the service secure and investing in enhancing enforcement strategies.
Online Marketplace Operations
Research also found communities with up to nine thousand participants marketing retatrutide using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, filled with images of slimming results, positive reviews and step-by-step guides for mixing or administering at residence.
Within moments of entering one community, a vendor shared contact information, where most transactions take place. The seller provided an instruction manual and promised delivery within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about body mass, medical conditions or previous experience.
Product Details and Pricing
Inside these communities, messages show black plastic parcels with postal service labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors typically sold at £160 for 20mg. When questioned how long a injector should last, vendors give conflicting responses ranging from a several days to “depends on your body”.
Platform Oversight and Safety Measures
A representative for Telegram said it regularly moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are injecting materials they cannot confirm. Although the science behind this drug is sound, these digital versions may not include what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.
A medical professional of an online medical service connected the surge in interest to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to social media. But fake treatments are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.
Her team has previously encountered patients harmed by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a company investigational substance not yet authorized … may expose users to possibly significant medical dangers”.
